Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities

Figure 1 Units of packed red blood cell transfused before and after initiation of thalidomide.

Figure 2 Endoscopic pictures of gastric antral vascular ectasia before and after treatment with thalidomide. A: Gastric antral vascular ectasia (GAVE) with visible bleeding prior to initiation of thalidomide; B: GAVE 3 mo after initiation of thalidomide; C: GAVE 8 mo after initiation of thalidomide.